Please assess the completion status of the following clinical trial:

Trial Title: Ethiopia Group Antenatal Care Study at the Health Post Level

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Minimum age of 15 years at the time of enrollment; pregnant 15-17 year-olds will be treated as emancipated/mature as per local regulations~* Gestational age less than or equal to 20 weeks at the time of enrollment determined by last menstrual period (LMP), pelvic exam, fundal height, quickening, ultrasound, and/or timing of fetal heart tones and pregnancy test~* Pregnant women able and willing to provide adequate locator information~* Planning to reside at their current location for at least 10 months~* Agree to participate in the study and continue ANC at health post~* Willing to participate and consent to follow up for up to 6 weeks post-delivery~* Are willing to receive group antenatal care at the health post level (during the intervention period)~Exclusion Criteria:~* Women who plan to travel away from the study site for more than four consecutive weeks during ANC or after 6 weeks post-delivery~* Women who are unable provide consent~* Women who have any condition that in the opinion of the investigator or designee, would complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: 49 Years
- Healthy Volunteers: t

Study Arms:
- Group ANC (Type: EXPERIMENTAL): Intervention period in stepped wedge design where women are receiving antenatal care in a group setting
- Individual ANC (routine) (Type: NO_INTERVENTION): Pre-intervention time period (control period) where the intervention is not being implemented yet (women are receiving individual antenatal care as is currently offered)

Based on this trial design, predict the completion outcome and termination type (if applicable).